md 780236 has been researched along with homovanillic acid in 1 studies
| Studies (md 780236) | Trials (md 780236) | Recent Studies (post-2010) (md 780236) | Studies (homovanillic acid) | Trials (homovanillic acid) | Recent Studies (post-2010) (homovanillic acid) |
|---|---|---|---|---|---|
| 12 | 0 | 0 | 6,127 | 312 | 438 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fuller, RW; Hemrick-Luecke, SK | 1 |
1 other study(ies) available for md 780236 and homovanillic acid
| Article | Year |
|---|---|
Influence of selective, reversible inhibitors of monoamine oxidase on the prolonged depletion of striatal dopamine by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Alkaloids; Animals; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Harmaline; Homovanillic Acid; Male; Mice; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Oxidation-Reduction; Pyridines | 1985 |